Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S241000
Reexamination Certificate
active
10544908
ABSTRACT:
A novel class of 3-oxo-3H-benzo[d]isoxazole carboxamide compounds is disclosed together with the use of such compounds for inhibiting hepatic lipase and/or endothelial lipase activity for treatment, amelioration or prevention of hepatic lipase and/or endothelial lipase mediated diseases.
REFERENCES:
patent: 2257750 (1974-05-01), None
patent: 0684242 (1995-11-01), None
patent: 0897903 (1999-02-01), None
Eacho Patrick Irving
Foxworthy-Mason Patricia Sue
Lin Ho-Shen
Lopez Jose Eduardo
Mosior Marian Kazimierz
Barker Michael P.
Eli Lilly and Company
Ginah Francis O.
Myers James B.
LandOfFree
Phospholipase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phospholipase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phospholipase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769033